For providers
Provider resources
Resources designed to support your practice
From videos and case studies to patient guides and more, find resources to help you use the Riskguard® test with your patients.
A healthcare provider with stethoscope interacting with a tablet device in her hand.

Exact Sciences Provider Hub

Submit and track orders, access test results, and more.
Case studies
Riskguard® + OncotypeDX® case study
PDF
Adding the Riskguard test to the Oncotype DX test can give you powerful information.
Riskguard® + OncoExTra® case study
PDF
See how adding the Riskguard test to the OncoExTra test can give you more answers.
Forms and billing resources
Test requisition form
PDF
If you prefer not to order on our Provider Hub, you can download the test requistition form and fax it to +1 715-406-4175. If you are collecting a sample in clinic, include a copy of the order form in the specimen kit.
ICD-10 codes
It is the healthcare provider’s responsibility to select the appropriate diagnosis code. To identify the appropriate ICD-10 code(s), we recommend reviewing the resources posted on the Centers for Medicare & Medicaid Services (CMS) website.
CPT codes
Depending on the diagnosis of cancer in the patient, and any family history of cancer, the procedure codes for the Riskguard® test may differ based upon the cancer indication and payor policy. Patients can contact 866-662-6897, option 2, option 1, to obtain further assistance from the billing team.

Call +1 866-662-6897

Informed consent form
PDF
This form describes the benefits, risks, and limitations of genetic testing for inherited susceptibility to cancer.
Billing and coverage info card
PDF
We're here to help. Our support team can help your patients navigate the insurance coverage process.
Sample reports
Negative sample report
PDF
Adding the Riskguard test to the Oncotype DX test can give you powerful information.
Positive BRCA1 sample report
PDF
See what the report could look like if your patient tests positive for a harmful gene change in BRCA1.
Uncertain sample report
PDF
An uncertain result means a change (referred to on a report as "variant of uncertain significance") was identified in a gene, but there is not enough data available yet to determine if that gene change actually increases cancer risk or if it is benign.
Patient education video
Specimen collection & shipping instructions
Blood sample
PDF
Peripheral whole blood specimen requirements and shipping guidelines.
Saliva sample
PDF
Saliva sample collection and shipping instructions.
Buccal sample
PDF
Buccal sample collection and shipping instructions.
Forms and billing resources
Sample family share letter
PDF
Patients with a positive Riskguard test result might have family members at risk of carrying the same germline variant. A family share letter can help patients communicate their results to relatives.
Gene list
PDF
Riskguard is a multigene test that may impact clinical decision-making in common cancer types.
Patient identification resources
PDF
See which risk factors and diagnoses make the Riskguard test a fit for your patients with cancer.
Specimen kits
Call customer care to request Riskguard test kits. We can send blood, saliva, or buccal test kits right to your office, or we can send a convenient at-home saliva test kit directly to your patient's address.*

Call +1 866-662-6897

Additional gene information
The Riskguard test evaluates 59 different genes. See our Gene Information page for more information about each and every one of them.
Sample letter of medical necessity
PDF
This is a resource for documenting medical necessity for possible use when testing medically appropriate patients to support coverage.
A healthcare provider talking to a patient, gesturing with his hands.

Ordering a test for your patients is fast and easy

Order tests, access results, and receive updates through your Provider Hub.

References and footnotes

  1. Riskguard test kits are provided at no charge and are to be used only with the Riskguard test.
The Exact Sciences Riskguard test was developed, and its performance characteristics validated by an Exact Sciences laboratory following College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) regulations. The test is performed in Marshfield, WI at PreventionGenetics LLC, a wholly owned subsidiary of Exact Sciences. PreventionGenetics is accredited by CAP, certified under CLIA regulations, and qualified to perform high-complexity clinical laboratory testing. It has not been cleared or approved by the US Food and Drug Administration or other notified regulatory authority. Genomic Health, Inc., an Exact Sciences company, is the billing entity for the Riskguard test.